BARX2 and pancreatic adenocarcinoma: The present study, based on the TCGA and GEO databases, shows the multifaceted prognostic impact of BARX2 overexpression on OS in certain tumour types, with higher BARX2 expression associated with better OS in KIRC, KIRP, LIHC, and SKCM and poorer OS in BLCA, KICH, LUAD, PAAD, and UVM.